Triumph Capital Management’s Organon & Co OGN Stock Holding History

Triumph Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91K	Sell	6,724 -3,417	-34%	-$40.9K	0.02%	512
2026 Q1	$60.7K	Sell	10,141 -170	-2%	-$1.28K	0.01%	580
2025 Q4	$73.9K	Sell	10,311 -1,516	-13%	-$12K	0.02%	512
2025 Q3	$126K	Sell	11,827 -78,515	-87%	-$771K	0.03%	314
2025 Q2	$875K	Buy	90,342 +47,127	+109%	+$486K	0.26%	91
2025 Q1	$643K	Buy	43,215 +4,655	+12%	+$71.6K	0.21%	122
2024 Q4	$575K	Buy	38,560 +4,402	+13%	+$71.7K	0.2%	134
2024 Q3	$653K	Sell	34,158 -24,819	-42%	-$514K	0.23%	107
2024 Q2	$1.22M	Buy	+58,977	New	+$1.17M	0.48%	51

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Triumph Capital Management's OGN Position: Q2 2026 in Review

Triumph Capital Management reduced its Organon & Co (OGN) stake by 34% in Q2 2026, selling an estimated $40.9K and leaving 6,724 shares worth $91K. The position accounts for 0.02% of the portfolio, ranked #512.

Triumph Capital Management first reported a position in OGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.22M in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Triumph Capital Management held 6,724 shares of Organon & Co worth $91K as of Q2 2026.
Triumph Capital Management sold 3,417 Organon & Co shares in Q2 2026, an estimated $40.9K.
Organon & Co made up 0.02% of Triumph Capital Management's portfolio in Q2 2026, its #512 holding.
Triumph Capital Management first reported a position in Organon & Co in Q2 2024 and has held it in 9 quarters since.
Triumph Capital Management's Organon & Co position peaked at $1.22M in Q2 2024.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.